Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01004380
Brief Title: Safety Study of Farletuzumab, Carboplatin and Pegylated Liposomal Doxorubicin (PLD) to Treat Platinum-sensitive Ovarian Cancer

First Submitted : October 20, 2009
First Submitted that Met QC Criteria : October 28, 2009
First Posted : October 29, 2009 (Estimate)

Last Update Submitted that Met QC Criteria : July 15, 2014
Last Update Posted : July 17, 2014 (Estimate)